Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Scheduling of Next Case Management Conference in Federal Pradaxa Bleeding Litigation

The firm is currently investigating Pradaxa lawsuits on behalf of individuals who suffered life-threatening episodes of internal bleeding, allegedly due to Pradaxa.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Free Case Review
We are pleased to see Pradaxa lawsuits moving forward, and look forward to additional progress in this litigation as it prepares for bellwether trials next fall.

New York, New York (PRWEB) August 04, 2013

Bernstein Liebhard LLP continues to monitor Pradaxa lawsuits (http://www.pradaxalawsuithelp.com/) currently pending in a multidistrict litigation underway in U.S. District Court, Southern District of Illinois. The next Case Management Conference in the federal Pradaxa litigation has been scheduled for August 8, 2013 at 9:30 p.m. According to court documents, more than 1,340 lawsuits have been filed in the Southern District of Illinois on behalf of individuals who allegedly suffered life-threatening episodes of Pradaxa bleeding. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)

“We are pleased to see Pradaxa lawsuits moving forward, and look forward to additional progress in this litigation as it prepares for bellwether trials next fall,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free legal evaluations to alleged victims of Pradaxa bleeding.

Pradaxa Side Effects
Pradaxa was approved in October 2010 to treat patients with atrial fibrillation. However, since Pradaxa came on the market, the drug has been the subject of a number of safety alerts in the U.S. and abroad, according to Bloomberg.com. While it was touted as an improvement over warfarin, there exists no readily available antidote for reversing the life-threatening internal bleeding that is a known Pradaxa side effect.* Late last year, a study published by the Institute for Safe Medicine Practices reported that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.

All of the Pradaxa lawsuits pending in the Southern District of Illinois allege that Boehringer Ingelheim failed to provide adequate warnings regarding Pradaxa side effects, particularly the lack of an antidote for internal bleeding. The first bellwether trial in the Pradaxa bleeding litigation is scheduled to start in September 2014.

Individuals who have suffered serious episodes of internal bleeding while taking Pradaxa may be entitled to compensation for their medical bills, lost wages, pain and suffering and more. Read More about Pradaxa side effects at Bernstein Liebhard LLP’s website. To arrange for a free legal consultation, please call 800-511-5092.

*bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html, Bloomberg.com, December 11, 2012

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com
http://www.pradaxalawsuithelp.com/